Daiichi’s Quizartinib And The Quintessential 'Pazdur Moment'

 
• By Michael McCaughan
  
Richard Pazdur
He looks friendly enough, but sponsors should try to avoid getting into an ODAC with him. • Source: FDA photo by Michael J. Ermarth
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers